Targeted therapies Defining the best-in-class in NSCLC

被引：5
|
作者：
Hutchinson, Lisa
机构：
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2017年 / 14卷 / 08期
关键词：
D O I：
10.1038/nrclinonc.2017.99
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [41] New FieldConnex® power hub for PROFIBUS with best-in-class system availability
    不详
    CHEMIE INGENIEUR TECHNIK, 2006, : 10 - 10
  • [42] Targeted therapies in the treatment of advanced/metastatic NSCLC
    Pallis, A. G.
    Serfass, L.
    Dziadziusko, R.
    van Meerbeeck, J. P.
    Fennell, D.
    Lacombe, D.
    Welch, J.
    Gridelli, C.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (14) : 2473 - 2487
  • [43] BENCHMARKING - METHODS OF RAISING COMPANY EFFICIENCY BY LEARNING FROM THE BEST-IN-CLASS
    Jetmarova, Barbora
    E & M EKONOMIE A MANAGEMENT, 2011, 14 (01): : 83 - 96
  • [44] Legend of titanic or how to search for hospital excellence: On best-in-class comparison
    von Eiff, Wilfried
    INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT, 2012, 5 (02) : 104 - 107
  • [45] LegNet: a best-in-class deep learning model for short DNA regulatory regions
    Penzar, Dmitry
    Nogina, Daria
    Noskova, Elizaveta
    Zinkevich, Arsenii
    Meshcheryakov, Georgy
    Lando, Andrey
    Rafi, Abdul Muntakim
    de Boer, Carl
    Kulakovskiy, Ivan, V
    BIOINFORMATICS, 2023, 39 (08)
  • [46] Towards "best-in-Class' Hsp90 inhibitors: A synthetic biology approach
    Martin, Christine J.
    Gaisser, Sabine
    Vousden, Bill
    Sheehan, Lesley S.
    Foster, Teresa
    Sheridan, Rose M.
    Nur-E-Alam, Mohammed
    Coates, Nigel
    Moss, Steven
    Beckman, Christoph
    Wilkinson, Barrie
    Gregory, Matthew
    Prodromou, Chris
    Pearl, Laurence
    Greiner, Thomas
    Bausch, Niko
    Zhang, Ming-Qiang
    DRUGS OF THE FUTURE, 2007, 32 : 11 - 12
  • [47] Trends in best-in-class energy-efficient technologies for room air conditioners
    Shah, Nihar
    Park, Won Young
    Ding, Chao
    ENERGY REPORTS, 2021, 7 : 3162 - 3170
  • [48] Tripokin: potential best-in-class for tumor targeted interleukin-2 (IL2) potentiated by tumor necrosis factor (TNF)
    Prodi, Eleonora
    Corbellari, Riccardo
    Matasci, Mattia
    Neri, Dario
    De Luca, Roberto
    CANCER RESEARCH, 2023, 83 (07)
  • [49] Software Paviilion: Exploring Digital Transformation Best-in-class solutions to optimize operations
    不详
    MANUFACTURING ENGINEERING, 2024, 173 (01):
  • [50] TRAIL apoptotic pathway-targeted therapies for NSCLC
    Bellail, Anita C.
    Hao, Chunhai
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (02) : 155 - 157
12345